• Net sales
  • Results
  • Cashflow
  • Share
  • Investments/​R&D
  • Currency effects
Sales
Results
Cashflow
Share
Investments/​R&D expenditures
Currency effects

Net sales +1.3% Currency-adjusted net sales growth in 2020

Chart is loading ...
Chart is loading ...
*Adjusted for costs in connection with the Sanitec acquisition and integration (EBITDA 2018 not adjusted)
Chart is loading ...
* Adjusted for costs in connection with the Sanitec acquisition and integration

Operating cashflow margin (EBITDA margin)
  31.0% +170 basis points higher than prior year

Free cashflow
(in CHF) 717 million +11.4% versus prior year

Earnings per share
(in CHF) 17.95 -0.1% versus prior year

Payout ratio

63.8% The payout ratio is in the upper range of the target corridor of 50 to 70%

Investments in property, plant and equipment and intangible assets
(in CHF) 150 million -10.2% versus prior year

R&D expenditures
(in CHF)

75 million 2.5% of net sales

Currency effects in EBIT
(in CHF) -43 million

Currency effects in net sales
(in CHF) -136 million